In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results